Abstract
Soon after levamisole became widely used as a veterinary anthelmintic, it was recognised that concurrent enhancement of immune responsiveness sometimes accompanied anthelmintic treatment, especially in old or chronically ill animals. There are many reports concerning the immunomodulatory effects of levamisole in immunocompromised and vaccinated animals, but information about the effects of levamisole in immunocompetent animals is limited and controversial. Thirty Holstein dairy calves were randomly divided into two groups: test (n=15) and control (n=15). Blood samples were taken from the jugular vein, between 24 h and 48 h after birth, and put into EDTA-containing tubes and plain tubes; levamisole was then administrated orally at a dose of 2 mg/kg body weight three times at 1-day intervals in test groups. Blood sampling from all the calves was continued at days 7, 14, 21 and 28. The weight of calves was measured only at days 1 and 28 (before feeding). The levels of packed cell volume (PCV) (microhaematocrit), total white blood cells (WBCS) and differential leukocyte count (manual standard methods), total serum protein (colorimetry), beta and gamma globulins (electrophoresis), albumin:globulin (A:G) (calculated) and disease occurrence were measured and recorded. Appropriate statistical methods were used for data analysis, and P≤0.05 was considered as significant. No significant differences were seen for PCV, total serum protein, WBC count and health between groups. In the test group, neutrophil level at day 14 and monocyte level at day 21 were significantly higher than in the control group (P<0.05). Electrophoresis showed no significant differences for beta globulin level and A:G between groups, but gamma globulin level at day 28 was significantly higher in the test group (P<0.05).
Similar content being viewed by others
References
Asif MM, Zia-ul-Rahman Naqvi ZH (1995) Effect of levamisole administered orally on haematological and biochemical profiles of Sahiwal heifers. Vet Arch 65:185–192
Babiuk LA, Misra V (1981) Levamisole and bovine immunity: in vitro and in vivo effects on immune responses to herpes virus immunization. Can J Microbiol 27:1312–1319
Babiuk LA, Misra V (1982) Effect of levamisole in immune responses to bovine herpes virus I. Am J Vet Res 43:1349–1354
Bekere RY (1988) Effect of levamisole on formation of natural immunity in neonatal calves, Teoreticheskie i Prakticheskie Voprosy Veterinarii: Materialy Respublikanskoi Konferentsii Dostizhenie Veterinarnoi Nauki i praktiki po povysheniyu produktivnosti sel, vol 2, pp 40–42
Boothe DM (2001) Immunomodulators or biologic response modifiers, introduction and miscellaneous agents. In: Boothe DM (ed) Small animal clinical pharmacology and therapeutics. Saunders, Philadelphia, pp 363–364
Cabaj W, Stankiewiez M, Jonas WE, Moore LG (1995) Levamisole and its influence on the immune response of lambs. Vet Res Commun 19:17–26
Courtney CH, Roberson EL (1995) Chemotherapy of parasitic diseases. In: Adams HR (ed) Veterinary pharmacology and therapeutics. Iowa State University Press, Ames, pp 900–904
Dacie JV, Lewis SM (1984) Practical haematology. Churchill Livingston, Edinburgh, pp 22–49
Deshpande AR, Gujar MB, Bannalikar AS (1991) Passive transfer of some immunological activities in newborn calves from levamisole treated dams. Indian Vet J 68:614–620
Findly VL, Munday BL (2000) The immunomodulatory effects of levamisole on the nonspecific immune system of Atlantic salmon Salmo salar. J Fish Dis 23:369–378
Goranov K, Bonovska M (1987) Effect of levamisole on the cytochemical function of leukocytes and on blood lysozyme in sheep. Vet Med Nauki 24:72–76
Hogarth-Scott RS, Liardet DM, Morris PJ (1980) Levamisole vaccine combinations: heightened antibody response. Aust Vet J 56:285
Hunter KW, Fischer GW, Sayles PC, Strickland GT (1981) Levamisole: potentiation of primary immunoglobulin M antibody responses in suckling rats. Immunopharmacology 3:117–127
Irwin MR, Holmberg CA, Knight HD, Hjerpe CA (1976) Effects of vaccination with infectious bovine rhinotracheitis and simultaneous administration of levamisole on primary humoral responses in calves. Am J Vet Res 37:223–226
Ivanov IE, Arsov R, Dimov I, Sizov I (1987) Effect of tuberculin and levamisole on the immune response after vaccinating calves against para influenza and salmonella infections. Vet Med Nauki 24:43–49
Jain NC (1986) Schalms veterinary hematology. Lea and Febiger, Philadelphia, pp 66–67
Keskar DV, Venkataraman R, Srinivasan SR, Dhanapalan P (1996) Prednisolone induced immunodeficiency in buffalo calves and its correction with levamisole. Indian Vet J 73:102–103
Kotowski K (1991) Wplyw wybranych preparatow na przebieg okresu poporodowego u krow i na stan zdrowotny noworodkow. Med Weter 47: 123–125
Krakowski L, Krzyzanowski J, Wrona Z, Siwicki AK (1999) The effect of nonspecific immunostimulation of pregnant mares with 1,3/1,6 glucan and levamisole on the immunoglobulins levels in colostrum selected indices of nonspecific cellular and humoral immunity in foals in neonatal and postnatal period. Vet Immunol Immunopathol 68:1–11
Nalini-Kumari K, Choudhuri PC (1986) Effect of levamisole on the haematological response of buffalo calves to rinderpest tissue culture vaccine Kerala. J Vet Sci 17:90–95
Ogunbiyi PO, Conlon PD, Black WD, Eyre P (1988) Levamisole induced attenuation of alveolar macrophage dysfunction in respiratory virus induced calves. Int J Immunopharmacol 10:377–385
Paulik S, Slanina L, Dubaj J, Boroskova Z, Benkova M, Szechenyi S (1989) Vplyv krvneho derivatu s imunomodulatorom na imunobielkovinovy profil u teliat v klinickych. Vet Med Praha 34:705–715
Paulik S, Svrcek S, Huska M, Mojzisova J, Durove A, Benisek Z (1992) The effect of fungal and yeast glucan and levamisole on the level of the cellular immune response in vivo and leukocyte phagocytic activity in mice. Vet Med Praha 37: 675–685
Qureishi ZI, Lodhi LA, Jamil H, Nawaz M (2000) Effect of levamisole hydrochloride on serum and colostral antibody titres against foot and mouth disease virus in vaccinated buffaloes (Bubalus bubalis). Vet Arch 70:59–66
Renoux G (1980) The general immunopharmacology of levamisole. Drugs 20:89–99
Roth JA, Kaeberle ML (1984) Effect of levamisole on lymphocyte blastogenesis and neutrophil function in dexamethasone-treated cattle. Am J Vet Res 45:1781–1784
Sharma LK, Jagadish S, Mulbagal AN (1990) Effects of haemorrhagic septicemia vaccination and levamisole administration on the humoral responses in cross bred calves. J Vet Pharmacol Ther 13:23–28
Singh KC, Dhawedkar RG (1993) Immunomodulating effects of levamisole in chicks immunocompromised by infectious bursal disease virus. Trop Anim Health Prod 25:11–14
Singla LD, Juyal PD (1992) Immunomodulatory effects of levamisole against Trypanosoma evansi infection in cow-calves serum gammaglobulins. J Vet Parasitol 6:9–14
Sopinska A, Guz I (1993) Immunostymuljace dzialanie lewamizolu i preparatu TFX-Polfa u warunkach eksperymentalnych. Med Weter 49:547–550
Stogause A, King MG (1995) Is oral levamisole immunostimulation in rats mediated by reduced levels of free plasma corticosterone?. Int J Immunopharmacol 17:635–640
Szeto C, Gillespie KM, Mathieson PW (2000) Levamisole induces interleukin 18 and shifts type 1/type 2 cytokine balances. Immunology 100:217–224
Wawron W, Szczubial M (2000) Stymulacja ukladu odpornosciowego krow i swin w okresie okeloporodowym. Med Weter 56:764–768
Wisniewski I, Grabowska G, Trybala E, Rotkiewcz Z (1993) Wplyw podonia biotropiny i lewamizolu na wybrane wskazniki odpornosci swoistej i nieswoistej u swin. Med Weter 49:66–68
Zia-ul-Rahman Z, Sandhu MA, Ahmad T (2003) Haematological and serum biochemical profiles of buffalo heifers as influenced by levamisole. Comp Clin Pathol 12:147–150
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohri, M., Seifi, H.A. & Zamani Sani, S.H. Effects of oral administration of levamisole on non-specific immunity, serum proteins and health in normal colostrum-fed neonatal dairy calves. Comp Clin Path 13, 132–136 (2005). https://doi.org/10.1007/s00580-004-0528-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-004-0528-0